NCT00867191View on ClinicalTrials.gov

Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)

PHASE4CompletedINTERVENTIONAL

Enrollment

233

Participants

Timeline

Start Date

February 1, 2002

Primary Completion Date

April 1, 2003

Study Completion Date

April 1, 2003

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

Placebo

Placebo, 1 tablet daily, per os., 15 days

DRUG

Desloratadine

Desloratadine, one 5 mg tablet daily, per os, 15 days

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00867191 - Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836) | Biotech Hunter | Biotech Hunter